Skip to main content

Beatty Liver and Obesity Research Program

The research portfolio includes development of diagnostic tests (called biomarkers) to predict an individual’s predisposition to disease and targeted therapies for those affected.

The urgency for this obesity research is clear. Obesity-related liver disease currently affects about 30 percent of the U.S. population and that number is expected to climb dramatically in the years ahead. Our investigators are shedding new light on this insidious disease and sharing their findings on the world stage. In the last few years, they have presented at numerous international conferences and written articles which have been published in important peer-reviewed journals. Such exposure adds to the body of research and positions Inova as a major player in this critical area of investigation.

The Beatty Liver and Obesity Research Program's objective is to generate innovative discoveries and pursue the development of novel biomarkers for the diagnosis and treatment of several important diseases by implementing personalized medicine protocols.

Inova Liver Disease Services

Offering comprehensive services to patients with chronic liver diseases.

Learn More

Clinical Trials

Explore clinical trials of new medications for the treatment of liver disease.

View Clinical Trials

Outcomes Research

Conducting research and support to clinical researchers in order to assess and improve patient outcomes. 

Learn More

Our Team

Meet our team of researchers and program managers led by internationally renowned physician-investigator, Dr. Lynn Gerber. 

Meet the Team